Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version

Glenmark denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.

from NDTV Profit - Latest https://ift.tt/3honnzA
via